CellTolerance®: A Breakthrough in Food Intolerance Diagnosis

The CellTolerance® Test ends years of trial-and-error diets by pinpointing food intolerances through live cellular imaging
Baptist Health, Compass Surgical Partners Advance Northeast Florida Surgery Network with Middleburg Surgery Center
Located in southeast Jacksonville near Baptist Medical Center Clay, the multispecialty ASC supports procedures in orthopedics, urology, otolaryngology, pain management, and general surgery. With 15 physician partners committed to the center, the partnership is evaluating expansion opportunities to meet growing demand.
Miniature laser technology could bring lab testing into your home
By studying how various biomolecules interact with each other – for example antibodies in the immune system and xenobiotic antigens – researchers can gain valuable insights leading to new medicines and vaccines or assess whether a sample contains signs of infection
First Multi Functional European Training in Augmented SBRT conducted in Monza
The clinic is currently conducting research into single-fraction treatment, where therapy is delivered in one session (while traditional radiotherapy requires 20–40 treatment sessions)
Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections
Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of our technology further underpins our belief in its potential to transform treatment paradigms for Gram-negative bacterial infections, filling an urgently needed gap in the market for new and effective treatment options for clinically vulnerable patients.”
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026
Medline Awards Distribution Center of the Year and SAFE Awards
These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility
Stryker launches SmartHospital Platform

“We are dedicated to partnering with our customers on their digital journeys to help elevate care delivery,” said Scott Sagehorn, VP/GM of Smart Care at Stryker. “The SmartHospital Platform is designed to evolve alongside health systems so teams can work more efficiently and stay focused on patient-centered care.”
John P Landino Appointed Chief Development Officer at Healogics

He brings nearly 20 years of experience in business development, marked by a proven ability to forge strategic partnerships with hospital executives and healthcare leaders, supporting rapid and sustainable organizational growth
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57
The Hidden Economic Cost of Falling Vaccination Rates | By David A. Dodd – CEO of GeoVax

Even small declines in measles vaccination coverage costs the United States billions, revealing why prevention infrastructure matters more than emergency response